Logo
  • About
  • Contact
  • (888) 441-8033

IMAGIA TO PRESENT AT BIOTECH SHOWCASE™ DIGITAL 2021

January 11, 2021 – Imagia, today announced that it is participating in Biotech Showcase™ 2021, and providing an on-demand company presentation. This year registered attendees to Biotech Showcase can access recorded company presentations beginning November 30th – SIX weeks prio...

View full release

ELEVIAN TO PRESENT AT BIOTECH SHOWCASE™ DIGITAL 2021

January 11, 2021 - Allston, MA – Elevian, Inc., today announced that it is participating in Biotech Showcase™ 2021, and providing an on-demand company presentation. This year registered attendees to Biotech Showcase can access recorded company presentations. 24x7 on-demand acc...

View full release

AIM Biotech to Present at Biotech Showcase™ 2021; To Highlight Expansion of its Organ-on-a-Chip Business

January 11, 2021 – AIM Biotech is participating in Biotech Showcase™ 2021, where CEO Jim McGorry will share the Company's plan to commercialize its organ-on-a-chip product line and contract research services. Registered attendees may access recorded company presentations prior...

View full release

NIBEC TO PRESENT AT BIOTECH SHOWCASE™ 2021

Seoul, Korea/January 11, 2021 – NIBEC Co., Ltd., today announced that it is participating in Biotech Showcase™ 2021 and providing an on-demand company presentation. This year registered attendees to Biotech Showcase can access recorded company presentations prior to the actual...

View full release

TauRx announces completion of Phase 3 study enrolment for the first tau-based disease modifying treatment for Alzheimer’s disease

Aberdeen, Scotland and Singapore [January 11, 2021] – TauRx Pharmaceuticals Ltd today announced it has completed patient enrolment of the LUCIDITY study (NCT03446001) ahead of schedule, despite delays due to the COVID-19 pandemic. TauRx is pleased to be presenting its latest t...

View full release

COVAXX Announces Early Design and Testing of New Vaccine Candidate to Address Mutations in SARS-CoV-2

NEW YORK (January 8, 2021) -- COVAXX, a U.S. company developing a multitope, peptide-based vaccine to fight COVID-19, announced today that the company has initiated preclinical work on a second vaccine candidate to address the latest mutations of the SARS-CoV-2 responsible for...

View full release

NOTABLE LABS TO PRESENT AT BIOTECH SHOWCASE™ DIGITAL 2021

FOSTER CITY, January 8, 2021 – Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced that it is participating in Biotech Showcase™ 2021 and will be presenting the strategic plan for lo...

View full release

CREO TO PRESENT AT BIOTECH SHOWCASE™ DIGITAL 2021

San Diego, CA – January 6, 2021 – Creo, an ingredient company with a proprietary platform for producing natural rare cannabinoids without the cannabis plant, today announced that it is participating in Biotech Showcase™ 2021 and providing an on-demand company presentation. Roy...

View full release

Pacylex Pharmaceuticals Announces Publication in Breast Cancer Research and Treatment of a New Target for Therapeutic Intervention in Breast Cancer and Preclinical Results of a First-in-Class Therapy

Edmonton, Alberta, Canada, January 6, 2021 - Pacylex Pharmaceuticals, an oncology company unlocking a new approach to cancer therapy, today announced the publication in the journal Breast Cancer Research and Treatment data showing treatment with an N-myristoyltransferase (NMT)...

View full release

“GaN Systems Cup” 2020 Winners Announced at China Power Supply Society Awards Ceremony

OTTAWA, Ontario, Canada, January 6, 2021 – GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, announced today the winners of the sixth annual “GaN Systems Cup” China Power Supply Society (CPSS) design competition at an awards ceremony at the CPSS Con...

View full release
  • « First
  • ‹ Prev
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • Next ›
  • Last »
©2026 Reportable, Inc.
Terms and Conditions | Privacy Policy